Continuous glucose monitoring for diabetic gastroparesis
Part of Digestive system, Hormones & metabolism, Immune system & allergy clinical trials.
This study tests whether a continuous glucose monitor (CGM) can help manage blood sugar in people with diabetes and gastroparesis (slow stomach emptying). If you have type 1 or type 2 diabetes and stomach symptoms, this could help doctors better understand your glucose patterns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 1 or type 2 diabetes for at least 1 year.
- Your average blood sugar (A1c) was 11% or lower in the last 6 months.
- You have had symptoms of gastroparesis (like nausea, vomiting, or feeling full quickly) for at least 3 months.
- You use an iPhone or Android smartphone that works with the LibreView app.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares wearing a continuous glucose monitor (CGM) all the time versus only now and then for people with type 2 diabetes who do not use insulin. It aims to see which way helps manage blood sugar better.
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
This study checks whether patient-guided lifestyle changes, supported by a continuous glucose monitor (a sensor), can improve blood sugar control in adults with type 2 diabetes. It may help you and your care team see how food, activity, and habits affect your readings.
This study compares using a continuous glucose monitor (a small sensor that tracks sugar levels all day) with the usual finger-prick testing in women with gestational diabetes. The goal is to see if the monitor helps control blood sugar better and is easier to use.
This study tests whether using a continuous glucose monitor (CGM) like the FreeStyle Libre 3 helps people with type 2 diabetes stay on their new GLP-1 or GIP/GLP-1 medication longer. You must be starting a GLP-1 or GIP/GLP-1 drug for the first time and not already using a CGM.
This study tests whether wearing a continuous glucose monitor (a small sensor that tracks blood sugar) can help people with heart failure and diabetes manage their health after being in the hospital. It may help doctors understand how blood sugar levels affect heart failure recovery.
Hear when a new Gastroparesis With Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.